Gilead Sciences reported $5.99B in Gross Profit on Sales for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Gross Profit On Sales Change
Agios Pharmaceuticals AGIO:US USD 3M 2.15M
ALKERMES ALKS:US USD 201.73M 16.13M
Alnylam Pharmaceuticals ALNY:US USD 223.19M 39.18M
Amgen AMGN:US USD 5.09B 28M
Biogen BIIB:US USD 2.04B 66.1M
Biomarin Pharmaceutical BMRN:US USD 389.06M 21.62M
Bluebird Bio BLUE:US USD 71K 297K
Bristol Myers Squibb BMY:US USD 8.89B 21M
Eli Lilly And LLY:US USD 5.75B 391.2M
Gilead Sciences GILD:US USD 5.99B 346M
Glaxosmithkline GSK:US GBP 5.2B 244M
GlaxoSmithKline GSK:LN GBP 5.2B 244M
Intercept Pharmaceuticals ICPT:US USD 77.16M 5.72M
Johnson & Johnson JNJ:US USD 15.94B 56M
Merk MRK:US USD 10.47B 610M
Moderna Inc MRNA:US USD 2.26B 1.1B
Neurocrine Biosciences NBIX:US USD 381.8M 8.4M
Novartis NOVN:VX USD 9.18B 151M
Pfizer PFE:US USD 14.47B 2.08B
Ptc Therapeutics PTCT:US USD 203.12M 47.23M
Regeneron Pharmaceuticals REGN:US USD 2.62B 58.3M
Sarepta Therapeutics SRPT:US USD 190.32M 5.38M
Teva Pharmaceutical Industries TEVA:US USD 1.71B 118M
United Therapeutics UTHR:US USD 478.8M 41.6M
Vertex Pharmaceuticals VRTX:US USD 2.04B 110.5M
YTE INCY:US USD 774.02M 92.14M